Fast Market Research

"Huntington's Disease (HD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" - New Market Report

Fast Market Research recommends "Huntington's Disease (HD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" from GlobalData, now available

 

Williamstown, MA -- (SBWIRE) -- 04/19/2012 -- GlobalData, the industry analysis specialist, has released its new report, "Huntington's Disease (HD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Huntington's Disease Therapeutics market. The report identifies the key trends shaping and driving the global Huntington's Disease Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Huntington's Disease Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

View Full Report Details and Table of Contents

Scope

The report provides information on the key drivers and challenges of the Huntington's Disease Therapeutics market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Huntington's Disease Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Huntington's Disease Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Huntington's Disease Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Huntington's Disease Therapeutics market

Reasons to Get this Report

The report will enhance your decision making capability. It will allow you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Huntington's Disease Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Huntington's Disease Therapeutics market in future.

Companies Mentioned in this Report: Valeant Pharmaceuticals, Avicena Group, NeuroSearch A/S

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Gaucher's Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Periodontal Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Kawasaki Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Paget's Disease of Bone (PDB) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Fabry's Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018